Subscribe to the BioNews newsletter for free

Advanced Search

Search for

Like the Progress Educational Trust on Facebook



Synthetic stem cells repair damaged hearts

09 January 2017

By Paul Waldron

Appeared in BioNews 883

Researchers in the US and China have developed a durable 'synthetic stem cell' that can repair tissue damaged by a heart attack.

Stem cell therapy carries risks, notably that the cells can divide out of control and form tumours, or that the body's immune system can reject the cells as foreign bodies. They are also complex and costly to produce and store. The scientists hope that their synthetic cells can bypass these risks, while offering comparable benefits to natural stem cells.

'We are hoping that this may be a first step toward a truly off-the-shelf stem cell product that would enable people to receive beneficial stem cell therapies when they're needed, without costly delays,' said Dr Ke Cheng of North Carolina State University, and a lead author of the study.

Stem cell therapies can regenerate organs and tissues by releasing of 'paracrine growth factors' – proteins and other substances which cause healing responses in the surrounding cells.

In the study, published in Nature Communications, the team made microparticles out of a biodegradable polymer and loaded them with growth factors secreted by cardiac stem cells. They then 'cloaked' these particles by coating them with membrane fragments taken from cardiac stem cells. The resulting synthetic stem cells are known as cell-mimicking microparticles (CMMPs).

The scientists added these CMMPs to lab-grown cultures of developing rat heart muscle cells. The CMMPs were able to bind to the developing cells, and increased both the production of heart cells and their ability to contract.

The researchers also injected the CMMPs into the hearts of mice that had undergone a simulated heart attack. Most of the CMMPs were retained in the heart, and after seven days the protective effects of the microparticles could be seen. The hearts pumped more blood, and the muscle cells had improved. Cell death and damage caused by the heart attack were also reduced.

These improvements were similar to those achieved by injecting cardiac stem cells, but did not provoke as much of an immune reaction. Furthermore, the CMMPs cannot replicate like natural stem cells or cause tumours.

'The synthetic cells operate much the same way a deactivated vaccine works,' said Dr Cheng. 'Their membranes allow them to bypass the immune response, bind to cardiac tissue, release the growth factors and generate repair, but they cannot amplify by themselves. So you get the benefits of stem cell therapy without risks.'

The particles are much more durable than stem cells, and can be frozen and thawed without damage. They also avoid the need to find an embryonic or patient source. The researchers hope that the same approach could be used to manufacture other types of stem cell.

North Carolina State University (press release) | 26 December 2016
Tech Times | 30 December 2016
Genetic Engineering and Biotechnology News | 27 December 2016
The Telegraph | 26 December 2016
Nature Communications | 03 January 2017


03 April 2017 - by Jennifer Willows 
A new method of producing red blood cells outside the body on a large scale has been developed by researchers at the University of Bristol...
27 March 2017 - by Dr Rachel Huddart 
Rapid advances in stem cell and embryo research are in danger of outstripping current ethical guidelines and new regulations are urgently needed, warn scientists in a report published this week...
06 February 2017 - by Emma Laycock 
Stem cell secretions, called exosomes, appear to protect retinal cells in rats, offering a potential therapy for degenerative eye diseases like glaucoma...

24 October 2016 - by Dr Katie Howe 
Scientists in Japan are the first to have created live mouse pups from eggs that were made from stem cells...
17 October 2016 - by Dr Jane Currie 
Researchers in Japan have used stem cells from a matched donor to repair damaged heart muscle in macaque monkeys...
12 September 2016 - by Dr Katie Howe 
Researchers in Belgium have taken the first steps towards producing a transplantable artificial ovary after demonstrating successful follicle survival in mice...
23 May 2016 - by Arit Udoh 
A group of scientists has been criticised for holding a high-level, behind-closed-doors meeting to discuss a project to synthesise a complete human genome within ten years...
22 February 2016 - by Kulraj Singh Bhangra 
Researchers in the USA have designed a 3D printer that can build living cells around a biodegradable structure to construct various artificial tissues...

Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions

- click here to enquire about using this story.

Published by the Progress Educational Trust


Public Conference
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation